abstract |
The present invention relates to the use of an elastase inhibitor, preferably the use of fascin for the treatment or prevention of emphysema, COPD or lung cancer. The elastase inhibitor is preferably administered via inhalation, preferably via tobacco smoke inhalation. The present invention also includes a smoking article comprising an elastase inhibitor. [Selection] Figure 1 |